Waystar Holding Corp. (WAY)
OvervaluedFundamental
60
Price
$28.85
Market Cap
$5.53B
Part 1 · What the company is worth
Overview
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$1.21B
Trailing 12 months (through 6/30/2026)
Net Income
$135M
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$283M
Total Equity
$3.88B
Total Liabilities
$1.91B
Current Ratio
1.85
Interest Coverage
-
Debt/EBITDA
3.80
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$20.87
Current Price
$28.85
Margin of Safety
-38.3%
Fair Value Range
$13.56 - $28.17
Spread across the valuation methods used, not a statistically calibrated confidence interval.
Estimation Methods
Valuation Metrics
P/E Ratio
41.21
ROE
2.9%
P/B Ratio
1.39
P/FCF
22.46
Gross Margin
-
ROIC
3.9%
Profitability Radar
Value Creation (Economic Moat)
ROIC
3.9%
WACC
9.4%
ROIC − WACC
-5.5 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental Analysis Criteria
Passed (13)
- EPS shows upward trend
- P/FCF 22.46
- P/B ratio 1.39
- Debt/equity ratio
- Operating margin 22.9%
- Positive free cash flow
- CapEx intensity
- Current ratio
- Debt/EBITDA
- Return on tangible assets
- Earnings surprise, average 2.5%
- Earnings quality (operating cash flow / net income) 2.17
- Net margin trend 11.2% vs 8.5%
Failed (8)
- Price CAGR -17.87%
- ROIC 3.9%
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- ROE 3.6%
- Share dilution 24.9%
- Piotroski F-Score 4/9
Unavailable (5)
- Gross margin –
- Dividend payout –
- Interest coverage
- Revenue growth 5Y
- PEG ratio (needs P/E > 0 and growth > 0)
Piotroski F-Score
Mixed signals: some areas need attention
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Issuing new shares, diluting ownership
Institutional Holdings
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Matthew J. Hawkins | CEO & Director | 53 |
| Mr. Steven M. Oreskovich CPA | Advisor | 53 |
| Mr. T. Craig Bridge | Chief Transformation Officer | 52 |
| Ms. Alpana Wegner CPA | Chief Financial Officer | 52 |
| Mr. Amit Khanna | Chief Product & Technology Officer | - |
| Mr. Anthony Carrozzella | Chief Growth Officer of Health Systems & Hospitals | - |
| Mr. Eric Avery | Senior VP of Business Operations & Intelligence | - |
| Mr. Dustin Hamilton | Senior Vice President of Product Management | - |
| Mr. Perry Sweet | Executive Vice President of Enterprise Client Experience | - |
| Ms. Amy Bishop | Senior Vice President of Performance Marketing | - |
Audit Risk
1
Board Risk
6
Compensation Risk
4
Shareholder Rights Risk
8
Documents
- View document
Annual Report (10-K)
A yearly overview of the business, its financial results, and the risks it faces.
Filed on 2026-02-17
- View document
Quarterly Report (10-Q)
A snapshot of financial performance for the most recent three-month period.
Filed on 2026-07-29
- View document
Current Report (8-K)
An announcement of a major event, such as a leadership change or big news.
Filed on 2026-07-29
via SEC EDGAR
Income History
via SEC EDGAR
Part 2 · The price and its context
This part shows how the price has behaved, not whether the company is worth owning. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Market Reaction Profile
How much WAY moves, measured on its daily prices.
More volatile than 81% of the tracked stocks (90-day volatility).
- Volatility 30d
- 44.9%
- Volatility 90d
- 55.2%
- Beta vs S&P 500 (1y)
- 0.52Correlation 0.12
- Max drawdown (12m)
- -56.3%
- ATR (14d, % of price)
- 3.71%
Earnings reactions
How WAY moved around its past quarterly results.
Next earnings release
Nov 2, 2026 · In 9 days · Time not known
EPS estimate: 0.41Revenue estimate: $323M
What usually happens
- Over the last 9 releases the stock moved a median of 7.7% the next day, up or down.
- Next-day moves: up 5, down 4 (out of 9).
Release history
| Date | When | EPS est. | EPS actual | Surprise | Gap | 1 day | 5 days |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | After the close | 0.40 | 0.43 | +7.4% | -12.4% | -14.6% | -4.6% |
| Apr 29, 2026 | After the close | 0.39 | 0.42 | +7.8% | -6.1% | -15.4% | -21.3% |
| Feb 17, 2026 | During the session | 0.40 | 0.36 | -9.5% | +4.9% | +8.5% | +8.7% |
| Oct 29, 2025 | After the close | 0.35 | 0.37 | +4.4% | -2.3% | -6.5% | -7.2% |
| Jul 30, 2025 | After the close | n/a | n/a | n/a | -2.8% | +3.8% | -4.6% |
| Apr 30, 2025 | After the close | n/a | n/a | n/a | +2.9% | +6.2% | +10.4% |
| Feb 18, 2025 | During the session | n/a | n/a | n/a | +1.1% | -0.5% | -7.2% |
| Nov 6, 2024 | After the close | n/a | n/a | n/a | +7.1% | +7.7% | +4.7% |
| Aug 7, 2024 | After the close | n/a | n/a | n/a | +2.0% | +10.5% | +14.4% |
Release dates from SEC 8-K filings.
Updated 10/24/2026
Historical statistics for educational purposes only. They are not forecasts and not investment advice.
Price reaction to the news
Latest news on WAY and what the price did next.
- 3/15/2026PositiveWaystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter
- +1 day
- +0.8%
- +3 days
- +2.2%
Return of the stock minus return of SPY over the same days. A news item close to a price move did not necessarily cause it. Historical data for educational purposes only, not investment advice.
Latest News
Recent headlines for WAY.
- 3/15/2026POSITIVEWaystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter
Despite a 32% stock decline over the past year, Waystar Holding Corp. has attracted significant investor interest, with one fund acquiring $11.5 million worth of shares in the last quarter. Waystar, a provider of cloud-based software for healthcare payment and revenue cycle management, appears to be viewed as undervalued by this particular investor. This substantial purchase, against a backdrop of recent poor stock performance, suggests a contrarian bet on the company's long-term prospects and its position within the healthcare technology sector.